Oncolytics Biotech Inc. (ONCY)
NASDAQ: ONCY
· Real-Time Price · USD
1.28
-0.03 (-2.29%)
At close: Sep 12, 2025, 10:06 AM
-2.29% (1D)
| Bid | 1.29 |
| Market Cap | 128.73M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | -30.41M |
| EPS (ttm) | -0.27 |
| PE Ratio (ttm) | -4.76 |
| Forward PE | -3.64 |
| Analyst | Buy |
| Ask | 1.3 |
| Volume | 146,804 |
| Avg. Volume (20D) | 1,189,116 |
| Open | 1.31 |
| Previous Close | 1.31 |
| Day's Range | 1.28 - 1.31 |
| 52-Week Range | 0.33 - 1.53 |
| Beta | 1.19 |
About ONCY
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol ONCY
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for ONCY stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts3 days ago
+20.75%
Oncolytics Biotech shares are trading higher after...
Unlock content with
Pro Subscription
3 months ago
+34.1%
Oncolytics Biotech shares are trading higher after the company announced it appointed Jared Kelly as CEO.
